Greg Luerman,
Technical Director
Dr. Greg Luerman is the Technical Director for Axiogenesis (North America). Following his graduate studies at the University of Louisville School of Medicine, Dr. Luerman earned a Michael J Fox Foundation postdoctoral fellowship within the Pfizer Neuroscience Research Unit. There he was the biology project lead on a small molecule kinase project. He moved on to establish multiple iPS-cardiomyocyte ion channel preclinical safety/tox and drug discovery services at ChanTest Corp. Now at Axiogenesis, Dr. Luerman oversees North American scientific project development, applications support, assay services, and regulatory body interactions.
|
|
|
